Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ectoine + hyaluronic acid
- Development stage
- Phase 4
- Lead developer
- URSAPHARM Arzneimittel
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical, Sublingual, Ophthalmic
01
Overview
**Ectoine + hyaluronic acid** is a non-systemic topical combination used in ocular-lubricating preparations and investigated in dermatologic cream formulations. Ectoine is a natural extremolyte with water-binding and membrane-stabilizing properties, while hyaluronic acid forms a bioadhesive, water-retaining lubricating film. In marketed HYLO ocular formulations, the combination hydrates the corneal and conjunctival surface, stabilizes the tear film and reduces tear evaporation, helping relieve dry-eye irritation and allergy-associated ocular symptoms. A 1% ectoine plus 0.1% hyaluronic acid cream has also been studied in children with mild-to-moderate atopic dermatitis.
- Brand names
- HYLO DUALHYLO DUAL INTENSE
- Other names
- ectoin + hyaluronic acidEHA creamhyaluronic acid + ectoine透明質酸 + ectoin
Beyond the preview
Go deeper on ectoine + hyaluronic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ectoine + hyaluronic acid.